Determined to reduce prices of syringes, needles, sutures, staples, packaging, tubing, catheters, medical gloves, and other heavily used medical consumables, Chinese authorities in July unveiled a series of new cost-containment measures. The moves include a pilot program that would permit groups of... Read More
China’s Center for Medical Device Evaluation (CMDE) has expanded the number of medium and high-risk medical devices exempt from clinical requirements. The new list includes 142 more medical devices than were previously exempted. Manufacturers of Class II and Class III medical devices... Read More
Moving to centralize decision-making on drug reimbursement practices, China’s National Healthcare Security Administration has drafted a plan to decrease the ability of provincial governments to make adjustments to the prices of pharmaceuticals. The agency, which since its formation last November has played... Read More
Four years after China established a pilot program enabling drug license holders to use third parties to manufacture their products, the National Medical Products Administration in August launched a database to allow drug makers and the public to more easily access information... Read More
With clinical research and regulatory filings booming in China, regulatory authorities are receiving a record number of drug applications for new clinical trials and drug approvals. Last year, more than 5,500 applications for technical review were filed with China’s Center for Drug... Read More
Registrations of new medical devices dropped sharply in China last year, with the overall level of registration activity down to its lowest level since China started publishing registration data six years ago. Initial registrations of medical devices with China’s National Medical Products Administration (NMPA)... Read More
The Trump administration will exempt certain categories of medical devices and medical equipment from hefty tariffs it slapped on $34 billion of Chinese imports to the U.S., offering relief to some U.S, firms. The narrow list of exemptions will provide relief from... Read More
Two years after Hainan Island, a popular Chinese tourist destination off the south coast of China, first emerged as a medical tourism hub, its authorities continue to grant special approval to foreign drugs and medical devices not legally available in mainland China.... Read More
Even as a fascination with new medical technologies powered by artificial intelligence (AI) increasingly takes hold in China, the country’s regulatory framework to manage this growth is still slowly evolving. Some Chinese hospitals are using robots to perform surgeries. Medical providers employ... Read More
Pushing to strengthen its supervision of drugs and medical devices across its vast market, China’s National Medical Products Administration in May launched a pilot data-sharing platform to track product information digitally across 17 provinces. If successful, the system will be fully operational across... Read More